NRP-1 was found to be elevated in multiple malignant tumors, such as breast cancer, lung cancer and gastric cancer 13-15, and participated in the promotion of tumor proliferation, epithelial-mesenchymal transition (EMT), invasion and migration 16-18. Here, NRP1 is linked to cancer.